GHRP-6 vs MOTS-c: What Is the Difference?
Both are notoriously fussy to store, for overlapping reasons. Beyond that they have almost nothing in common.
In plain English
GHRP-6 is a six-amino-acid molecule from the 1980s that triggers growth hormone release — and famously led researchers to discover a hormone nobody knew existed.
MOTS-c is a sixteen-amino-acid molecule encoded inside mitochondrial DNA, studied as a signal that mitochondria send out about their energy status.
The difference, without the jargon
They sit in unrelated research areas — growth hormone signalling versus cellular energy sensing — but share a storage problem worth understanding. Both contain tryptophan, the amino acid most easily damaged by light. GHRP-6 contains two copies of it, doubling the exposure, and visibly yellows as it degrades. MOTS-c contains one, plus methionine, which reacts with oxygen, so it has two different vulnerabilities operating at once. In both cases the practical answer is the same: keep them dark, minimise air exposure, and portion them promptly rather than repeatedly opening one vial. GHRP-6 also has the better story — it was built before anyone identified the receptor it acts on, and chasing that receptor eventually led to the discovery of ghrelin in 1999.
Common questions
What is the difference between GHRP-6 and MOTS-c?
GHRP-6 triggers growth hormone release and belongs to endocrine research. MOTS-c is encoded in mitochondrial DNA and belongs to cellular energy research. They are unrelated in purpose but share sensitivity to light.
Why do both need dark storage?
Both contain tryptophan, the amino acid most vulnerable to light. GHRP-6 has two copies of it, and MOTS-c pairs its one with methionine, which reacts with oxygen. Either way, darkness and minimal air exposure are genuine requirements.
What does yellowing mean?
It is light damage becoming visible. In a tryptophan-containing molecule, a yellow or tan tint in what should be white powder is a meaningful sign of degradation rather than a cosmetic variation.
Technical reference below
How they actually differ
Comparing the two: GHRP-6 is synthetic hexapeptide, met-enkephalin analogue and ghrelin-receptor agonist, while MOTS-C is mitochondrial-derived peptide, 16 residues — different molecular classes with different handling consequences; their leading degradation routes differ (tryptophan photo-oxidation at two independent positions for GHRP-6, methionine oxidation to the sulfoxide (+16 da), and mots-c carries methionine at the n-terminus and internally. for MOTS-C), so the storage precautions that matter are not the same. The sections below set out each in full.
GHRP-6 — origin
GHRP-6 was among the first synthetic growth hormone secretagogues, developed from met-enkephalin analogues in the 1980s — years before the ghrelin receptor it acts on was even identified. It is a genuine piece of pharmacological history: the compound was found first and its target second, and that search for the endogenous ligand of its receptor eventually led to the discovery of ghrelin in 1999.
MOTS-C — origin
MOTS-c is encoded not in nuclear DNA but within the mitochondrial genome — specifically an open reading frame inside the 12S ribosomal RNA gene. Its discovery helped establish that mitochondria encode short signalling peptides that act on the rest of the cell, a genuinely recent addition to cell biology and the reason the compound attracted rapid research interest.
GHRP-6 research themes
Acts at GHS-R1a — the receptor whose search for an endogenous ligand led to ghrelin's discovery.
Strong GH-releasing activity in research models, historically the compound's defining property.
Ghrelin-receptor activity links it to appetite pathways in metabolic research models.
A landmark in reverse pharmacology: the synthetic ligand preceded knowledge of both receptor and natural ligand.
MOTS-C research themes
Part of a novel class demonstrating that mitochondria encode peptides acting systemically.
The most-studied signalling interaction, examined in metabolic and exercise models.
Investigated in glucose-metabolism research models.
Studies have examined MOTS-c expression in relation to physical activity and ageing in animal models.
GHRP-6 handling
- Amber vials or foil wrapping should be treated as required, not optional.
- Reconstitute under reduced lighting where practical.
- Avoid contact with trace metals, which catalyse oxidative degradation of aromatic residues.
MOTS-C handling
- Use amber vials or wrap in foil; treat light protection as mandatory rather than precautionary.
- Minimise vial openings — headspace oxygen is the practical driver of oxidation.
- Use low-bind labware for dilute working solutions.
Both third-party tested
Every Popular Peptides batch of GHRP-6 and MOTS-C is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
GHRP-6 reference
Related comparisons
GHRP-6 and MOTS-C are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.